Wearable tech helps people manage multiple sclerosis

Wearable tech helps people manage multiple sclerosisUniversity of Alberta researchers are teaming up with a precision-health innovator to develop a low-cost wearable sensor to help people suffering from chronic neurologic conditions treat their illness remotely, while reducing the frequency and costs of hospital visits. Hossein Rouhani, an assistant professor in the Faculty of Engineering and primary investigator in the Neuromuscular Control and Biomechanics Laboratory,…

Salt-coated masks can kill COVID-19

Salt-coated masks can kill COVID-19In 2017, Hyo-Jick Choi and his engineering research team released a study outlining a breathable surgical mask that just doesn’t catch pathogens from entering the respiratory system; it kills them. Choi, a professor in the Faculty of Engineering who runs the Sustainable Engineering and Drug Delivery Design (SEƎD) lab, developed the idea of an antiviral, antibacterial filter for a…

Sound engineer for Prince to talk about brilliant partnership

Now a professor of music psychology, Susan Rogers will also discuss music and psychology in two virtual presentations for the U of A’s music department

Sound engineer for Prince to talk about brilliant partnershipSusan Rogers needed just one more lucrative gig to go back to school. It wasn’t that she didn’t already have a hugely successful career. She cut her teeth as a studio technician with David Crosby and Graham Nash after dropping out of high school, and was hired by Prince as staff technician in the early…

COVID-19 creating new paradigm for developing vaccines

It’s showing us how fast we can develop them when the will is there

COVID-19 creating new paradigm for developing vaccinesEarlier this year, Michael Houghton, University of Alberta virologist and co-recipient of the 2020 Nobel Prize in Physiology or Medicine, mobilized his hepatitis C lab to join the charge to produce a vaccine for COVID-19. His lab was a perfect fit for the endeavour, having created a successful vaccine for the SARS virus in 2004 that…

New drug to treat muscular dystrophy based on U of A research

Created using synthetic DNA, viltolarsen is an excellent example of precision medicine

New drug to treat muscular dystrophy based on U of A researchA University of Alberta researcher’s past work has led to a new drug being approved for use in the United States to treat patients suffering from Duchenne muscular dystrophy (DMD). The drug, viltolarsen, was approved for use in Japan earlier this year and passed a significant hurdle in August when the U.S. Food and Drug…

Paleontologists identify new species of mosasaur

Paleontologists identify new species of mosasaurA new species of an ancient marine reptile evolved to strike terror into the hearts of the normally safe, fast-swimming fish has been identified by a team of University of Alberta researchers. The discovery sheds light on what it took to survive in highly competitive ecosystems. Gavialimimus almaghribensis, a new type of mosasaur, was catalogued and…

Diamonds found in Far North offer clues to Earth’s early history

Though the diamonds found are quite small the geologic implications are immense

Diamonds found in Far North offer clues to Earth’s early historyThe presence of diamonds in an outcrop atop an unrealized gold deposit in Canada’s Far North mirrors the association found above the world’s richest gold mine, according to University of Alberta research that fills in blanks about the thermal conditions of Earth’s crust three billion years ago. “The diamonds we have found so far are…

Type 2 diabetes drug buys time for a failing heart: study

The diabetes drug increased ketone levels, which might be the key to improving cardiac metabolism

Type 2 diabetes drug buys time for a failing heart: studyIn 2015, researchers began noticing that a drug used to treat Type 2 diabetes, empagliflozin, came with the added benefit of decreasing hospitalization for heart failure and death from cardiovascular causes in those patients. “It was very unexpected, because this drug is targeted and marketed for Type 2 diabetes, not heart failure,” said Kim Ho,…